[1]
“Analysis of Excellent Response, Persistent Disease and Recurrent Diseases of Radioiodine Treatment on Differentiated Thyroid Carcinoma Patients- 42 Years’ Experience at NINMAS”, Bangladesh J. Nuclear Med., vol. 25, no. 2, pp. 81–87, Jul. 2022, doi: 10.3329/bjnm.v25i2.64642.